MetaCap

TherapeuticsMD Insider Trades

NASDAQ: TXMDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.06+0.05 (+2.49%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $14.03K
Sales
0 · $0
Shares bought / sold
8.40K / 0
Net activity
Net buying $14,031

TherapeuticsMD insider activity

Over the last 12 months, TherapeuticsMD insiders reported 1 transaction on SEC Form 4: 1 open-market purchase and 0 sales. Insiders bought $14,031 and sold $0 worth of stock, for net insider buying of $14,031. The most recent filing shows Thompson Tommy G (Director) buying 8,400 shares at $1.67 on Dec 23, 2025.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TXMD's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TXMD insider transactions

TherapeuticsMD insider transactions
DateInsiderTypeSharesValueFiling
Dec 23, 2025Thompson Tommy GDirectorBuy8,400$14.03KForm 4
Apr 14, 2025Walker Marlan DChief Executive OfficerBuy490$489.27Form 4
Apr 14, 2025Thompson Tommy GDirectorBuy325$325.58Form 4
Apr 10, 2025Walker Marlan DChief Executive OfficerBuy1,167$1.00KForm 4
Apr 9, 2025Walker Marlan DChief Executive OfficerBuy1,136$993.66Form 4
Feb 18, 2025Thompson Tommy GDirectorOption exercise8,500—Form 4
Feb 18, 2025Walker Marlan DChief Executive OfficerOption exercise1,733—Form 4
Feb 18, 2025Walker Marlan DChief Executive OfficerOption exercise770—Form 4
Feb 18, 2025Walker Marlan DChief Executive OfficerOption exercise2,311—Form 4
Feb 18, 2025Walker Marlan DChief Executive OfficerOption exercise3,467—Form 4
Feb 18, 2025Naughton Gail KDirectorOption exercise8,500—Form 4
Feb 18, 2025Collins Cooper C.DirectorOption exercise8,500—Form 4
Aug 22, 2024Collins Cooper C.DirectorBuy4,094$7.10KForm 4
Aug 21, 2024Collins Cooper C.DirectorBuy1,200$2.04KForm 4
Dec 7, 2023Walker Marlan DChief Executive OfficerSale4,550$10.19KForm 4
Dec 6, 2023Walker Marlan DChief Executive OfficerSale14,500$33.50KForm 4
Dec 5, 2023Walker Marlan DChief Executive OfficerOption exercise70,000—Form 4
Nov 15, 2023Rubric Capital Management LP & Rosen David EfraimDirectorAward877,192$2.00MForm 4
Aug 17, 2023ZIEGLER JOSEPHPrincipal Financial OfficerAward7,500—Form 4
Jun 28, 2023Rubric Capital Management LP & Rosen David EfraimDirectorAward312,525$1.15MForm 4
Apr 26, 2023Walker Marlan DChief Executive OfficerSale692$2.52KForm 4
Apr 26, 2023Walker Marlan DChief Executive OfficerOption exercise1,734—Form 4
Apr 26, 2023Walker Marlan DChief Executive OfficerOption exercise1,010—Form 4
Apr 12, 2023Donegan Michael CPrin. Fin. and Acctg. OfficerOption exercise50,000—Form 4
Apr 12, 2023Walker Marlan DChief Executive OfficerSale1,170$4.28KForm 4
Apr 12, 2023Walker Marlan DChief Executive OfficerOption exercise1,734—Form 4
Apr 12, 2023Walker Marlan DChief Executive OfficerOption exercise1,734—Form 4
Apr 12, 2023Walker Marlan DChief Executive OfficerOption exercise1,010—Form 4
Apr 12, 2023Walker Marlan DChief Executive OfficerOption exercise3,030—Form 4
Jan 27, 2023Donegan Michael CPrin. Fin. and Acctg. OfficerSale49$249.41Form 4
Jan 26, 2023Donegan Michael CPrin. Fin. and Acctg. OfficerSale1,648$8.37KForm 4
Jan 26, 2023Donegan Michael CPrin. Fin. and Acctg. OfficerOption exercise1,140—Form 4
Jan 26, 2023Donegan Michael CPrin. Fin. and Acctg. OfficerOption exercise2,400—Form 4
Jan 26, 2023Donegan Michael CPrin. Fin. and Acctg. OfficerOption exercise2,400—Form 4
Jan 24, 2023Donegan Michael CPrin. Fin. and Acctg. OfficerSale7$37.17Form 4
Jan 23, 2023Donegan Michael CPrin. Fin. and Acctg. OfficerSale1,302$6.95KForm 4
Jan 23, 2023Donegan Michael CPrin. Fin. and Acctg. OfficerOption exercise2,400—Form 4
Jan 23, 2023Donegan Michael CPrin. Fin. and Acctg. OfficerOption exercise519—Form 4
Jan 23, 2023Donegan Michael CPrin. Fin. and Acctg. OfficerOption exercise1,066—Form 4
Jan 23, 2023Donegan Michael CPrin. Fin. and Acctg. OfficerOption exercise380—Form 4
Dec 30, 2022Rubric Capital Management LP & Rosen David Efraim10% OwnerSale29,000$38.66MForm 4
Dec 30, 2022Rubric Capital Management LP & Rosen David EfraimDirectorDisposition29,000$38.66MForm 4
Dec 9, 2022Bernick BrianCo-Chief Executive OfficerSale320$2.02KForm 4
Dec 9, 2022Rubric Capital Management LP & Rosen David Efraim10% OwnerBuy14,825$90.28KForm 4
Dec 8, 2022Rubric Capital Management LP & Rosen David Efraim10% OwnerBuy300$1.75KForm 4
Dec 7, 2022Naughton Gail KDirectorSale3,922$20.64KForm 4
Dec 7, 2022Rubric Capital Management LP & Rosen David Efraim10% OwnerBuy20,113$113.89KForm 4
Dec 6, 2022Donegan Michael CInterim CFO/CAO/VP of FinanceSale910$4.35KForm 4
Dec 6, 2022Donegan Michael CInterim CFO/CAO/VP of FinanceOption exercise262—Form 4
Dec 6, 2022Donegan Michael CInterim CFO/CAO/VP of FinanceOption exercise534—Form 4
Dec 6, 2022Donegan Michael CInterim CFO/CAO/VP of FinanceOption exercise380—Form 4
Dec 6, 2022Donegan Michael CInterim CFO/CAO/VP of FinanceOption exercise2,300—Form 4
Dec 6, 2022Glickman Mark ACo-Chief Executive OfficerSale440$2.17KForm 4
Dec 6, 2022Glickman Mark ACo-Chief Executive OfficerOption exercise1,734—Form 4
Dec 6, 2022Walker Marlan DGeneral CounselSale1,048$5.18KForm 4
Dec 6, 2022Walker Marlan DGeneral CounselOption exercise388—Form 4
Dec 6, 2022Walker Marlan DGeneral CounselOption exercise1,156—Form 4
Dec 6, 2022Walker Marlan DGeneral CounselOption exercise1,010—Form 4
Dec 6, 2022Bernick BrianCo-Chief Executive OfficerSale935$4.60KForm 4
Dec 6, 2022Bernick BrianCo-Chief Executive OfficerOption exercise3,167—Form 4
Oct 28, 2022Rubric Capital Management LP & Rosen David Efraim10% OwnerBuy7,000$7.00MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related